ATE431419T1 - Alzheimer krankheit sekretase, app (amyloid vorlaüfer-protein) substrate dafür und verwendungen - Google Patents
Alzheimer krankheit sekretase, app (amyloid vorlaüfer-protein) substrate dafür und verwendungenInfo
- Publication number
- ATE431419T1 ATE431419T1 AT00965338T AT00965338T ATE431419T1 AT E431419 T1 ATE431419 T1 AT E431419T1 AT 00965338 T AT00965338 T AT 00965338T AT 00965338 T AT00965338 T AT 00965338T AT E431419 T1 ATE431419 T1 AT E431419T1
- Authority
- AT
- Austria
- Prior art keywords
- alzheimer
- app
- substrates
- precursor protein
- amyloid precursor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6478—Aspartic endopeptidases (3.4.23)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
- G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
- G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
- G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
- G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
- G01N2333/96472—Aspartic endopeptidases (3.4.23)
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Toxicology (AREA)
- Neurology (AREA)
- Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15549399P | 1999-09-23 | 1999-09-23 | |
| US40413399A | 1999-09-23 | 1999-09-23 | |
| US09/416,901 US6699671B1 (en) | 1998-09-24 | 1999-10-13 | Alzheimer's disease secretase, APP substrates therefor, and uses therefor |
| US16923299P | 1999-12-06 | 1999-12-06 | |
| PCT/US2000/026080 WO2001023533A2 (en) | 1999-09-23 | 2000-09-22 | Alzheimer's disease secretase, app substrates therefor, and uses therefor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE431419T1 true ATE431419T1 (de) | 2009-05-15 |
Family
ID=34753605
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00965338T ATE431419T1 (de) | 1999-09-23 | 2000-09-22 | Alzheimer krankheit sekretase, app (amyloid vorlaüfer-protein) substrate dafür und verwendungen |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP1224297B1 (de) |
| AR (1) | AR025754A1 (de) |
| AT (1) | ATE431419T1 (de) |
| AU (1) | AU782312B2 (de) |
| CA (1) | CA2397786A1 (de) |
| CO (1) | CO5770112A1 (de) |
| DK (1) | DK1224297T3 (de) |
| ES (1) | ES2327312T3 (de) |
| PE (1) | PE20010693A1 (de) |
| PT (1) | PT1224297E (de) |
| TW (2) | TWI294462B (de) |
| WO (1) | WO2001023533A2 (de) |
Families Citing this family (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7456007B1 (en) | 1998-12-31 | 2008-11-25 | Elan Pharmaceuticals, Inc. | β-secretase enzyme compositions and methods |
| US7115410B1 (en) | 1999-02-10 | 2006-10-03 | Elan Pharmaceuticals, Inc. | β-secretase enzyme compositions and methods |
| JP4653318B2 (ja) | 1999-02-10 | 2011-03-16 | エラン ファーマシューティカルズ，インコーポレイテッド | βセクレターゼ酵素組成物および方法 |
| WO2000058479A1 (en) | 1999-03-26 | 2000-10-05 | Amgen Inc. | Beta secretase genes and polypeptides |
| CA2374610A1 (en) | 1999-06-28 | 2001-01-04 | Jordan J. N. Tang | Catalytically active recombinant memapsin and methods of use thereof |
| US7514408B1 (en) | 1999-12-02 | 2009-04-07 | Elan Pharmaceuticals, Inc. | β-secretase enzyme compositions and methods |
| ATE343562T1 (de) | 2000-03-23 | 2006-11-15 | Elan Pharm Inc | Verbindungen und verfahren zur behandlung der alzheimerschen krankheit |
| US6713276B2 (en) * | 2000-06-28 | 2004-03-30 | Scios, Inc. | Modulation of Aβ levels by β-secretase BACE2 |
| EP1666452A2 (de) | 2000-06-30 | 2006-06-07 | Elan Pharmaceuticals, Inc. | Verbindungen zur Behandlung der Alzheimerischen Krankheit |
| PE20020276A1 (es) | 2000-06-30 | 2002-04-06 | Elan Pharm Inc | COMPUESTOS DE AMINA SUSTITUIDA COMO INHIBIDORES DE ß-SECRETASA PARA EL TRATAMIENTO DE ALZHEIMER |
| US7217556B1 (en) | 2000-12-23 | 2007-05-15 | Pfizer Inc | Crystallization and structure determination of glycosylated human beta secretase, an enzyme implicated in Alzheimer's disease |
| US7601528B1 (en) | 2000-12-23 | 2009-10-13 | Elan Pharmaceuticals, Inc. | Crystallization and structure determination of glycosylated human beta secretase, an enzyme implicated in alzheimer's disease |
| US7806980B2 (en) | 2000-12-23 | 2010-10-05 | Elan Pharmaceuticals, Inc. | Method for crystallizing human beta secretase in complex with an inhibitor |
| US7384773B1 (en) | 2001-05-10 | 2008-06-10 | Pfizer Inc | Crystal of HIV protease-cleaved human beta secretase and method for crystallization thereof |
| US7524668B1 (en) | 2001-05-10 | 2009-04-28 | Elan Pharmaceuticals, Inc. | Crystal of human beta secretase having monoclinic space group symmetry C2 and methods for crystallization thereof |
| US7144897B2 (en) | 2001-06-01 | 2006-12-05 | Elan Oharmaceuticals, Inc. | Hydroxy alkyl amines |
| MXPA03011521A (es) | 2001-06-13 | 2004-03-18 | Elan Pharm Inc | Aminadioles para tratamiento de enfermedad de alzheimer. |
| MXPA04000338A (es) | 2001-07-10 | 2004-07-23 | Upjohn Co | Diamindioles para tratamiento de enfermedad de alzheimer. |
| JP2005505517A (ja) | 2001-07-10 | 2005-02-24 | イーラン ファーマスーティカルズ、インコーポレイテッド | アルツハイマー病を治療するためのアミンジオール |
| EP1409660A2 (de) * | 2001-07-26 | 2004-04-21 | Astex Technology Limited | Kristallstruktur des beta-site app-spaltungs-enzym (bace) und ihre verwendung |
| US7186539B1 (en) | 2001-08-31 | 2007-03-06 | Pharmacia & Upjohn Company | Method for refolding enzymes |
| CA2462851A1 (en) | 2001-10-04 | 2003-04-10 | Elan Pharmaceuticals, Inc. | Hydroxypropylamines |
| CA2464736A1 (en) | 2001-10-23 | 2003-05-15 | Oklahoma Medical Research Foundation | Beta-secretase inhibitors and methods of use |
| US7045311B2 (en) | 2001-10-25 | 2006-05-16 | Monogram Biosciences, Inc. | Whole cell assay systems for cell surface proteases |
| KR20050044407A (ko) | 2001-11-08 | 2005-05-12 | 엘란 파마슈티칼스, 인크. | N,n'-치환-1,3-디아미노-2-히드록시프로판 유도체 |
| EP1572904B1 (de) | 2002-02-21 | 2009-04-15 | Pharmacia & Upjohn Company LLC | Modifizierte bace |
| US7262208B2 (en) | 2002-04-30 | 2007-08-28 | Elan Pharmaceuticals, Inc. | Hydroxypropyl amides for the treatment of Alzheimer's disease |
| US7442537B1 (en) | 2002-05-10 | 2008-10-28 | Elan Pharmaceuticals, Inc. | Crystals of unliganded beta secretase and/or beta secretase-like proteins and the use thereof |
| JP2004000060A (ja) * | 2002-05-31 | 2004-01-08 | Otsuka Pharmaceut Co Ltd | アミロイドβ産生に影響を与える化合物のスクリーニング方法 |
| US7351738B2 (en) | 2002-11-27 | 2008-04-01 | Elan Pharmaceuticals, Inc. | Substituted ureas and carbamates |
| BRPI0409624A (pt) | 2003-04-21 | 2006-04-18 | Elan Pharm Inc | 2-hidróxi-3-diaminoalcanos de benzamida |
| WO2004099402A1 (en) | 2003-05-02 | 2004-11-18 | Elan Pharmaceuticals, Inc. | Glycosylation variants of bace |
| CA2558034A1 (en) | 2004-03-09 | 2005-09-22 | Elan Pharmaceuticals, Inc. | Substituted hydroxyethylamine aspartyl protease inhibitors |
| WO2006010095A2 (en) | 2004-07-09 | 2006-01-26 | Elan Pharmaceuticals Inc. | Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitors |
| US7906625B2 (en) | 2005-01-24 | 2011-03-15 | Amgen Inc. | Humanized anti-amyloid antibody |
| WO2007047305A1 (en) | 2005-10-12 | 2007-04-26 | Elan Pharmaceuticals, Inc. | Methods of treating amyloidosis using cyclopropyl derivative aspartyl protease inhibitors |
| TW200815349A (en) | 2006-06-22 | 2008-04-01 | Astrazeneca Ab | New compounds |
| JP5450407B2 (ja) | 2007-07-06 | 2014-03-26 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 置換アミノ−キナゾリノン、前記化合物を含む薬物、それらの使用及び製造方法 |
| TW201020244A (en) | 2008-11-14 | 2010-06-01 | Astrazeneca Ab | New compounds |
| EP2281824A1 (de) | 2009-08-07 | 2011-02-09 | Noscira, S.A. | Furan-Imidazolon-Derivate zur Behandlung von kognitiven, neurodegenerativen oder neuronalen Erkrankungen oder Funktionsstörungen |
| EP2643299B1 (de) | 2010-11-22 | 2016-06-22 | Noscira, S.A. | Bipyridinsulfonamidderivate zur behandlung von neurodegenerativen erkrankungen oder zuständen |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH09178743A (ja) * | 1995-12-27 | 1997-07-11 | Oriental Yeast Co Ltd | 可溶性ａｐｐの定量法 |
| EP0848062A3 (de) * | 1996-12-14 | 2000-07-05 | Smithkline Beecham Corporation | Aspartylprotease ASP1 |
| WO1999033963A1 (en) * | 1997-12-31 | 1999-07-08 | Chiron Corporation | Metastatic cancer regulated gene |
| CN1502696A (zh) * | 1998-09-24 | 2004-06-09 | �������Ŷ���Լ��������˾ | 阿尔茨海默氏疾病分泌酶 |
-
2000
- 2000-09-22 EP EP00965338A patent/EP1224297B1/de not_active Expired - Lifetime
- 2000-09-22 CA CA002397786A patent/CA2397786A1/en not_active Abandoned
- 2000-09-22 ES ES00965338T patent/ES2327312T3/es not_active Expired - Lifetime
- 2000-09-22 PT PT00965338T patent/PT1224297E/pt unknown
- 2000-09-22 PE PE2000000993A patent/PE20010693A1/es not_active Application Discontinuation
- 2000-09-22 WO PCT/US2000/026080 patent/WO2001023533A2/en active IP Right Grant
- 2000-09-22 DK DK00965338T patent/DK1224297T3/da active
- 2000-09-22 CO CO00072196A patent/CO5770112A1/es not_active Application Discontinuation
- 2000-09-22 AR ARP000104987A patent/AR025754A1/es unknown
- 2000-09-22 AU AU76071/00A patent/AU782312B2/en not_active Ceased
- 2000-09-22 AT AT00965338T patent/ATE431419T1/de active
- 2000-09-27 TW TW089119610A patent/TWI294462B/zh not_active IP Right Cessation
- 2000-09-27 TW TW096126353A patent/TW200745552A/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TW200745552A (en) | 2007-12-16 |
| ES2327312T3 (es) | 2009-10-28 |
| EP1224297B1 (de) | 2009-05-13 |
| AR025754A1 (es) | 2002-12-11 |
| WO2001023533A3 (en) | 2002-05-10 |
| TWI294462B (en) | 2008-03-11 |
| PE20010693A1 (es) | 2001-06-24 |
| CO5770112A1 (es) | 2007-06-29 |
| PT1224297E (pt) | 2009-08-17 |
| AU7607100A (en) | 2001-04-30 |
| EP1224297A2 (de) | 2002-07-24 |
| CA2397786A1 (en) | 2001-04-05 |
| DK1224297T3 (da) | 2009-09-07 |
| WO2001023533A2 (en) | 2001-04-05 |
| AU782312B2 (en) | 2005-07-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE431419T1 (de) | Alzheimer krankheit sekretase, app (amyloid vorlaüfer-protein) substrate dafür und verwendungen | |
| GB2367060B (en) | Alzheimer's disease secretase,app substrates therefor,and uses therefor | |
| DE60037057D1 (de) | Halbleiterelement und Herstellungsverfahren dafür | |
| DE60030279D1 (de) | Halbleiterbasis, ihre herstellungsmethode und halbleiterkristallherstellungsmethode | |
| DE69939575D1 (de) | Entdeckung von Diensten in unmittelbarer Nähe | |
| DK1443955T3 (da) | PDGF-BB til behandling af Parkinsons sygdom | |
| DE60132777D1 (de) | Benzothiazolderivate zur behandlung von alzheimer und parkinson | |
| DE60008039D1 (de) | Treibriemen und Herstellungsverfahren dafür | |
| DE60023782D1 (de) | Kleinstmotor und sein Herstellungsverfahren | |
| NO20001870L (no) | Ny fremgangsmÕte for behandling | |
| NO20022087D0 (no) | Fremgangsmåte for behandling av diabetes | |
| FI19992782A (fi) | Sanomavälityspalvelu | |
| DE60040320D1 (de) | Substratdrehvorrichtung | |
| ATE285951T1 (de) | Orginalitätsverschluss und herstellungverfahren | |
| DE60208186D1 (de) | Chinazolin- und chinazolinähnliche verbindungen zur behandlung von integrinvermittelten erkrankungen | |
| DE60045580D1 (de) | Einweg-Wischtuch und Herstellverfahren | |
| DE60038323D1 (de) | Halbleiterkristall, dessen Herstellungsverfahren und Halbleiterbauelement | |
| NO20011409D0 (no) | Farmasøytiske midler for behandling av Parkinsonssykdom, ADHD og mikroadenomer | |
| DE60044777D1 (de) | Siliziumwafer und dessen herstellung | |
| DE60210535D1 (de) | Vibrator und Herstellungsverfahren desselben | |
| DE60012592D1 (de) | Halbleiterlaser und zugehöriges Herstellungsverfahren | |
| DE69917826D1 (de) | Keramisches Substrat und dessen Polierverfahren | |
| NO20013337D0 (no) | Ny behandling | |
| EE04263B1 (et) | Farmatseutiline kompositsioon piperidinoalkanoolantihistamiini ja selle derivaatide biosaadavuse suurendamiseks ning allergiliste reaktsioonide raviks patsiendil | |
| DE60115012D1 (de) | Wischerarm und herstellverfahren |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1224297 Country of ref document: EP |
|
| UEP | Publication of translation of european patent specification |
Ref document number: 1224297 Country of ref document: EP |